Inventor · disambiguated record
Kenneth L. Luskey
Also filed as: LUSKEY KENNETH · LUSKEY KENNETH L
12 granted patents·4 pending applications·279 citations·filing 1999–2020
91Inventor score
Top patents by PatentIndex Score
16 records- 0195US8298561B2Rapid establishment and/or termination of substantial steady-state drug deliveryALESSI THOMAS R·Filed 2010·Granted Oct 30, 2012·30 cites·14 claims
- 0295US6613802B1Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemiaMETABOLEX INC·Filed 2000·Granted Sep 2, 2003·98 cites·6 claims
- 0391US6646004B1Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemiaMETABOLEX INC·Filed 2000·Granted Nov 11, 2003·40 cites·17 claims
- 0489US6624194B1Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemiaMETABOLEX INC·Filed 2000·Granted Sep 23, 2003·38 cites·17 claims
- 0587US6262118B1Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemiaMETS OLEX INC·Filed 1999·Granted Jul 17, 2001·61 cites·11 claims
- 0680US7576131B2Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemiaMETABOLEX INC·Filed 2003·Granted Aug 18, 2009·12 cites·21 claims
- 0774US12042557B2Rapid establishment and/or termination of substantial steady-state drug deliveryINTARCIA THERAPEUTICS INC·Filed 2020·Granted Jul 23, 2024·0 cites·24 claims
- 0869US8354448B2Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetesMETABOLEX INC·Filed 2009·Granted Jan 15, 2013·0 cites·14 claims
- 0963US10869830B2Rapid establishment and/or termination of substantial steady-state drug deliveryINTARCIA THERAPEUTICS INC·Filed 2018·Granted Dec 22, 2020·0 cites·21 claims
- 1062US2007270490A1Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemiaMETABOLEX INC·Filed 2007·Application pending·0 cites
- 1160US10231923B2Rapid establishment and/or termination of substantial steady-state drug deliveryINTARCIA THERAPEUTICS INC·Filed 2016·Granted Mar 19, 2019·0 cites·34 claims
- 1259US8329749B2Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemiaLUSKEY KENNETH L·Filed 2009·Granted Dec 11, 2012·0 cites·13 claims
- 1359US2013030417A1Rapid Establishment and/or Termination of Substantial Steady-State Drug DeliveryINTARCIA THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 1456US2005075396A1Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemiaMETABOLEX INC·Filed 2003·Application pending·0 cites
- 1550US8481597B2Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemiaLUSKEY KENNETH·Filed 2012·Granted Jul 9, 2013·0 cites·9 claims
- 1646US2004039053A1Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemiaFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kenneth L. Luskey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →